93 related articles for article (PubMed ID: 27987634)
1. A Differential Item Functioning Analysis of the EQ-5D in Cancer.
Smith AB; Cocks K; Parry D; Taylor M
Value Health; 2016 Dec; 19(8):1063-1067. PubMed ID: 27987634
[TBL] [Abstract][Full Text] [Related]
2. An Investigation of Age-Related Differential Item Functioning in the EQ-5D-5L Using Item Response Theory and Logistic Regression.
Penton H; Dayson C; Hulme C; Young T
Value Health; 2022 Sep; 25(9):1566-1574. PubMed ID: 35487819
[TBL] [Abstract][Full Text] [Related]
3. Differential item functioning in quality of life measurement: An analysis using anchoring vignettes.
Knott RJ; Lorgelly PK; Black N; Hollingsworth B
Soc Sci Med; 2017 Oct; 190():247-255. PubMed ID: 28881208
[TBL] [Abstract][Full Text] [Related]
4. Differential item functioning impact in a modified version of the Roland-Morris Disability Questionnaire.
Crane PK; Cetin K; Cook KF; Johnson K; Deyo R; Amtmann D
Qual Life Res; 2007 Aug; 16(6):981-90. PubMed ID: 17443419
[TBL] [Abstract][Full Text] [Related]
5. Quality of life and utility in patients with non-small cell lung cancer. Quality-of-life Study Group of the Master 2 Project in Pharmacoeconomics.
Trippoli S; Vaiani M; Lucioni C; Messori A
Pharmacoeconomics; 2001; 19(8):855-63. PubMed ID: 11596837
[TBL] [Abstract][Full Text] [Related]
6. Mapping the COPD Assessment Test onto EQ-5D.
Hoyle CK; Tabberer M; Brooks J
Value Health; 2016 Jun; 19(4):469-77. PubMed ID: 27325339
[TBL] [Abstract][Full Text] [Related]
7. Clinicians' Views on Therapeutic Outcomes of Systemic Interventions and on the Ability of the EQ-5D to Capture these Outcomes.
Schawo SJ; Brouwer WBF; Hakkaart L
J Ment Health Policy Econ; 2017 Sep; 20(3):131-136. PubMed ID: 28869211
[TBL] [Abstract][Full Text] [Related]
8. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY
PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745
[TBL] [Abstract][Full Text] [Related]
9. Mapping the FACT-P to the preference-based EQ-5D questionnaire in metastatic castration-resistant prostate cancer.
Skaltsa K; Longworth L; Ivanescu C; Phung D; Holmstrom S
Value Health; 2014 Mar; 17(2):238-44. PubMed ID: 24636382
[TBL] [Abstract][Full Text] [Related]
10. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
Hawton A; Green C; Telford C; Zajicek J; Wright D
Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
[TBL] [Abstract][Full Text] [Related]
11. Measuring preference-based quality of life using the EuroQol EQ-5D in patients with cerebral aneurysms.
King JT; Tsevat J; Roberts MS
Neurosurgery; 2009 Sep; 65(3):565-72; discussion 572-3. PubMed ID: 19687702
[TBL] [Abstract][Full Text] [Related]
12. Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer.
Rowen D; Young T; Brazier J; Gaugris S
Value Health; 2012 Dec; 15(8):1059-68. PubMed ID: 23244808
[TBL] [Abstract][Full Text] [Related]
13. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
Rutten-van Mölken MP; Oostenbrink JB; Tashkin DP; Burkhart D; Monz BU
Chest; 2006 Oct; 130(4):1117-28. PubMed ID: 17035446
[TBL] [Abstract][Full Text] [Related]
14. Validation of the EuroQol questionnaire in cardiac rehabilitation.
Schweikert B; Hahmann H; Leidl R
Heart; 2006 Jan; 92(1):62-7. PubMed ID: 15797936
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the performance of the EQ-5D and the EQ-5D-Y health-related quality of life instruments in South African children.
Jelsma J
Int J Rehabil Res; 2010 Jun; 33(2):172-7. PubMed ID: 20351650
[TBL] [Abstract][Full Text] [Related]
16. Association between "loco-check" and EuroQol, a comprehensive instrument for assessing health-related quality of life: a study of the Japanese general population.
Iizuka Y; Iizuka H; Mieda T; Tajika T; Yamamoto A; Takagishi K
J Orthop Sci; 2014 Sep; 19(5):786-91. PubMed ID: 25023927
[TBL] [Abstract][Full Text] [Related]
17. Estimating an EQ-5D-5L Value Set for China.
Luo N; Liu G; Li M; Guan H; Jin X; Rand-Hendriksen K
Value Health; 2017 Apr; 20(4):662-669. PubMed ID: 28408009
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life and utility in patients with advanced non-small-cell lung cancer: a prospective cross-sectional patient survey in a real-world setting.
Chouaid C; Agulnik J; Goker E; Herder GJ; Lester JF; Vansteenkiste J; Finnern HW; Lungershausen J; Eriksson J; Kim K; Mitchell PL
J Thorac Oncol; 2013 Aug; 8(8):997-1003. PubMed ID: 23787802
[TBL] [Abstract][Full Text] [Related]
19. Health utility measured with EQ-5D in Thai patients undergoing peritoneal dialysis.
Sakthong P; Kasemsup V
Value Health; 2012; 15(1 Suppl):S79-84. PubMed ID: 22265072
[TBL] [Abstract][Full Text] [Related]
20. Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values.
Hernández Alava M; Wailoo AJ; Ara R
Value Health; 2012 May; 15(3):550-61. PubMed ID: 22583466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
